| Literature DB >> 16680126 |
Abstract
Biopharmaceutical manufacturing capacity has moved through three discrete chapters in its 25-year history. Could the next chapter herald formal manufacturing-capacity sharing among companies?Mesh:
Year: 2006 PMID: 16680126 DOI: 10.1038/nbt0506-503
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908